Miroslav Radman wins the 2011 FEMS-Lwoff Award.
Deinove announced that Miroslav Radman (the company's co-founder and the Joint Chairman of its Scientific Advisory Board) has been presented with the 2011 Lwoff Award by the Federation of European Microbiological Societies (FEMS). Professor Radman has been honoured for his discoveries in the field of the molecular mechanisms of DNA damage repair and their role in carcinogenesis and evolution and for the discovery of the mechanism that enables the bacterium Deinococcus radiodurans to "come back to life" in a few hours by repairing and reorganizing its genetic material.
"We are delighted that Miroslav Radman has won the 2011 FEMS-Lwoff Award. It constitutes a magnificent acknowledgment of his major discoveries concerning Deinococcus - discoveries which prompted the creation of Deinove. Thanks to Miroslav's patented work, Deinove is now the only company in the world exploiting deinococci-specific genetic tools and using them in industrial applications", commented Deinove CEO Jacques Biton.
Miroslav Radman's work has brought to light the deinococci's unique self-repair ability - a property which has enabled these bacteria to enrich their genome through natural evolution over 3 billion years. It has notably enabled them to develop an exceptional natural ability to exploit biomass by borrowing genes from other living organisms. The ability to integrate these survival genes has made the deinococci exceptionally robust and productive candidates for industrial exploitation.
Other news from the department people

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
HIV-derived antibacterial shows promise against drug-resistant bacteria
Eisai Receives Approval for a New Oral Jelly Formulation of Aricept for the Treatment of Alzheimer’s Disease in Japan
Zelluna Immunotherapy appoints Miguel Forte as Chief Executive Officer - Appointment to drive Zelluna through next stage of international clinical-phase development
Pepscan Therapeutics establishes a Research Collaboration with Tibotec Pharmaceuticals
Sigma-Aldrich and Sangamo BioSciences Announce Alliance to Develop Zinc Finger-Based Laboratory Research Reagents
Cardio3 BioSciences Receives ISO-13485 Certification
Gene Logic Expands International Operations - Establishes Staff in UK and Germany - Forms Gene Logic K.K. to Serve Japanese Market

New way in which insulin interacts with its receptor discovered
Addex Awarded Michael J. Fox Foundation Grant for ADX48621 to treat Levodopa-Induced Dyskinesia in Parkinson's
